Albert David Ltd
☆ Add to Watchlist
Investing Reference
Trading Reference
AI Probability Statement
Probability Statement
Albert David Ltd is currently trading near a key support level, with recent volume indicating strong buying interest. If the stock can break above the resistance level at ₹X, there is potential for a price increase. However, if it falls below the support level at ₹Y, it may face significant downside risk.
Probability estimates are technical-context statements, not investment advice.
More Options
Business Overview
Albert David Ltd is a prominent player in the Indian pharmaceutical and healthcare sector, specializing in the manufacture and distribution of high-quality healthcare products. Catering to a diverse audience, including hospitals and retail pharmacies, the company is committed to improving health outcomes across the nation. With a strong focus on innovation and quality, Albert David Ltd stands out for its extensive product range and reliable service, making it a trusted partner in healthcare.
- Established leader in the pharmaceutical industry
- Wide range of healthcare products
- Focus on quality and innovation
- Trusted by hospitals and pharmacies
- Commitment to improving health outcomes
- Strong market presence in India
Investment Thesis
Albert David Ltd stands out due to its strong promoter group and credibility in the market. With a robust focus on digital services, the company is well-positioned for growth. Additionally, its attractive valuation compared to peers makes it a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation metrics compared to industry peers provide a margin of safety.
- Established brand presence in the healthcare sector supports revenue stability.
- Strategic initiatives in innovation and expansion are set to drive future growth.
Opportunity vs Risk
- Growing demand for healthcare products
- Expansion into new markets
- Strong brand recognition
- Rising e-commerce sales
- Strategic partnerships with suppliers
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Fluctuating raw material costs
- Economic downturns impacting sales
Peer Perspective
Albert David Ltd trades at a discount to peers like Cipla and Sun Pharma, with a P/E ratio reflecting its growth potential. A rerating could occur if the company achieves consistent margin stability and accelerates revenue growth.
Future Outlook
Albert David Ltd is well-positioned for growth in the coming quarters, provided it maintains strong execution and cost control measures. Continued focus on innovation and market expansion will be key to unlocking its full potential.
AI FAQs for Retail Users
- Q: What does Albert David Ltd do?A: Albert David Ltd is involved in manufacturing and marketing pharmaceutical products and healthcare solutions.
- Q: Is Albert David Ltd a good investment?A: Investment decisions should be based on individual research and financial goals. Consult a financial advisor.
- Q: What are the recent financial results of Albert David Ltd?A: You can find the latest financial results in their quarterly reports available on their website.
- Q: How can I buy shares of Albert David Ltd?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: What are the risks of investing in Albert David Ltd?A: Like all investments, risks include market volatility, regulatory changes, and company-specific factors.
-
8BusinessHighThe company operates in the pharmaceutical sector, which is generally future-ready with a clear business model.
-
10GrowthHighRevenue and profit growth have been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, but cash flow from operations is not consistently strong.
-
6ValuationGoodP/E and P/B ratios are higher than industry peers, indicating potential overvaluation.
-
7BalanceHighThe company has a manageable debt/equity ratio, but liquidity could be improved.
-
8GovernanceHighPromoter holding is decent, but there are some concerns regarding disclosures.
-
5DriversGoodGrowth catalysts are limited, and execution risks are present.
-
2TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100